Back to top

Barclays Reaffirms Their Buy Rating on Omada Health, Inc. (OMDA)

Barclays analyst Saket Kalia maintained a Buy rating on Omada Health, Inc. today and set a price target of $25.00. Kalia covers the Technology sect...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: